GENSCRIPT USA INC

GenScript USA Inc. specializes in advanced biotechnological services centered on recombinant protein and nucleic acid production, with deep expertise in monoclonal antibody development, gene synthesis, plasmid cloning, and custom biomolecule manufacturing. The company delivers end-to-end solutions for research and clinical applications, including high-throughput gene construct design, automated plasmid preparation, and scalable biological product manufacturing under GMP-like conditions. Their technical capabilities span molecular biology, synthetic biology, and analytical laboratory workflows, with demonstrated proficiency in supporting NIH-funded research on infectious diseases such as RSV and cancer immunotherapy through precise, reproducible biotherapeutic production. Differentiators include rapid turnaround for complex molecular constructs and integrated platforms for antibody discovery and DNA vector engineering. The contractor maintains a strong, consistent relationship with the Department of Health and Human Services, primarily serving NIH components including the National Cancer Institute and the Center for Cancer Research. Work performed includes support for cutting-edge biomedical research, providing critical reagents such as monoclonal antibodies, gene constructs, and purified plasmids that enable preclinical studies and therapeutic development. Engagement is focused on mission-critical, high-precision biological services rather than administrative or infrastructure support. Industry focus is firmly rooted in biotechnology research and development (NAICS 541714) and testing laboratories (541380), with complementary capabilities in biological product manufacturing (325414) and specialized medical laboratory services. The firm positions itself as a high-throughput, research-grade service provider for government-funded life sciences, bridging academic discovery and translational applications through scalable, GMP-aligned production systems. GenScript USA Inc. is a privately held entity based in Piscataway, New Jersey, with no federal certifications on record. Its geographic presence is centralized, serving federal research agencies through a specialized, science-driven operational model focused on precision biologics and molecular tools.